AXSM
Price
$107.85
Change
-$1.90 (-1.73%)
Updated
Apr 3, 04:59 PM (EDT)
Capitalization
5.26B
38 days until earnings call
JBPHF
Price
$0.29
Change
-$0.07 (-19.44%)
Updated
Feb 20 closing price
Capitalization
376.08M
Ad is loading...

AXSM vs JBPHF

Header iconAXSM vs JBPHF Comparison
Open Charts AXSM vs JBPHFBanner chart's image
Axsome Therapeutics
Price$107.85
Change-$1.90 (-1.73%)
Volume$15.01K
Capitalization5.26B
Jacobio Pharmaceuticals Group
Price$0.29
Change-$0.07 (-19.44%)
Volume$5K
Capitalization376.08M
AXSM vs JBPHF Comparison Chart
Loading...
AXSM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AXSM vs. JBPHF commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AXSM is a Buy and JBPHF is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (AXSM: $107.89 vs. JBPHF: $0.29)
Brand notoriety: AXSM and JBPHF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AXSM: 85% vs. JBPHF: 100%
Market capitalization -- AXSM: $5.26B vs. JBPHF: $376.08M
AXSM [@Biotechnology] is valued at $5.26B. JBPHF’s [@Biotechnology] market capitalization is $376.08M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AXSM’s FA Score shows that 0 FA rating(s) are green whileJBPHF’s FA Score has 0 green FA rating(s).

  • AXSM’s FA Score: 0 green, 5 red.
  • JBPHF’s FA Score: 0 green, 5 red.
According to our system of comparison, AXSM is a better buy in the long-term than JBPHF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AXSM’s TA Score shows that 4 TA indicator(s) are bullish.

  • AXSM’s TA Score: 4 bullish, 6 bearish.

Price Growth

AXSM (@Biotechnology) experienced а -11.40% price change this week, while JBPHF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.91%. For the same industry, the average monthly price growth was -11.19%, and the average quarterly price growth was -14.86%.

Reported Earning Dates

AXSM is expected to report earnings on May 12, 2025.

Industries' Descriptions

@Biotechnology (-8.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AXSM($5.26B) has a higher market cap than JBPHF($376M). AXSM YTD gains are higher at: 29.713 vs. JBPHF (0.000).
AXSMJBPHFAXSM / JBPHF
Capitalization5.26B376M1,399%
EBITDA-272.6MN/A-
Gain YTD29.7130.000-
P/E RatioN/AN/A-
Revenue386MN/A-
Total Cash315MN/A-
Total Debt193MN/A-
FUNDAMENTALS RATINGS
AXSM: Fundamental Ratings
AXSM
OUTLOOK RATING
1..100
4
VALUATION
overvalued / fair valued / undervalued
1..100
93
Overvalued
PROFIT vs RISK RATING
1..100
62
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
42
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AXSM
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
83%
Momentum
ODDS (%)
Bearish Trend 2 days ago
68%
MACD
ODDS (%)
Bearish Trend 7 days ago
87%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 11 days ago
78%
Declines
ODDS (%)
Bearish Trend 2 days ago
81%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
83%
Aroon
ODDS (%)
Bearish Trend 2 days ago
80%
View a ticker or compare two or three
Ad is loading...
AXSM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
EWC41.590.46
+1.12%
iShares MSCI Canada ETF
BSL14.120.01
+0.07%
Blackstone Senior Floating Rate 2027 Term Fund
FGB4.28N/A
N/A
First Trust Specialty Finance and Financial Opportunities Fund
NUGT61.60-0.02
-0.03%
Direxion Daily Gold Miners Bull 2X ETF
CEW17.56-0.01
-0.06%
WisdomTree Emerging Currency Strat ETF

AXSM and

Correlation & Price change

A.I.dvisor indicates that over the last year, AXSM has been loosely correlated with VANI. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if AXSM jumps, then VANI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AXSM
1D Price
Change %
AXSM100%
-1.72%
VANI - AXSM
36%
Loosely correlated
-0.98%
PLRX - AXSM
35%
Loosely correlated
+2.92%
SWTX - AXSM
34%
Loosely correlated
+11.08%
CRNX - AXSM
34%
Loosely correlated
+2.51%
ACHV - AXSM
34%
Loosely correlated
+1.59%
More

JBPHF and

Correlation & Price change

A.I.dvisor indicates that over the last year, JBPHF has been closely correlated with RAPT. These tickers have moved in lockstep 79% of the time. This A.I.-generated data suggests there is a high statistical probability that if JBPHF jumps, then RAPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JBPHF
1D Price
Change %
JBPHF100%
N/A
RAPT - JBPHF
79%
Closely correlated
-0.85%
AXSM - JBPHF
32%
Poorly correlated
-1.72%
PYPD - JBPHF
23%
Poorly correlated
-1.43%
FRTX - JBPHF
22%
Poorly correlated
N/A
LXRX - JBPHF
21%
Poorly correlated
+8.40%
More